Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma

BACKGROUND: Patients with advanced ovarian cancer should be treated by radical debulking surgery aiming at complete tumor resection. Unfortunately about 70% of the patients present with advanced disease, when optimal debulking can not be obtained, and therefore these patients gain little benefit fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegazy, Mohamed AF, Hegazi, Refaat AF, Elshafei, Mohamed A, Setit, Ahmed E, Elshamy, Maged R, Eltatoongy, Mohamed, Halim, Amal AF
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236969/
https://www.ncbi.nlm.nih.gov/pubmed/16135251
http://dx.doi.org/10.1186/1477-7819-3-57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236969/
https://www.ncbi.nlm.nih.gov/pubmed/16135251
http://dx.doi.org/10.1186/1477-7819-3-57

Ejemplares similares